Related Experiment Videos
Summary
Diagnosing syphilis relies on detecting Treponema pallidum. Specific antibody tests like FTA-ABS and VDRL, alongside IgM detection, help confirm active infection and monitor treatment effectiveness.
Area of Science:
- Infectious Diseases
- Immunology
- Clinical Diagnostics
Background:
- Definitive diagnosis of syphilis hinges on identifying Treponema pallidum in early specimens.
- Serological tests detect antibodies against T. pallidum, crucial for diagnosis when direct visualization is challenging.
Purpose of the Study:
- To describe the techniques, interpretation, reactivity, and potential errors of various syphilis diagnostic assays.
- To highlight the significance of IgM antibodies in indicating active syphilis and treatment response.
Main Methods:
- Review of diagnostic techniques including VDRL (RPR), FTA-ABS, TPHA (MHA-TP, AMHA-TP), and their IgM variants.
- Evaluation of antibody detection in serum and cerebrospinal fluid (CSF).
Main Results:
- The presence of 19S IgM antibodies signifies active syphilis; their absence suggests cure.
- VDRL tests indicate active disease but lack precision; elevated TPHA index in CSF suggests neurosyphilis.
- IgM-SPHA positivity in CSF is also indicative of neurosyphilis.
Conclusions:
- A combination of haemagglutination assay and VDRL is suggested for initial screening.
- FTA-ABS is recommended for diagnostic confirmation.
- Monitoring IgM-SPHA or VDRL titres aids in assessing treatment response.